COURSE DESCRIPTIONThe meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery, the role of prophylactic mastectomy, the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, neoadjuvant chemotherapy and its role in restaging breast cancer, nipple-sparing mastectomy both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast
reconstruction.

Attendees will hear different models for coordination of breast cancer from major centers across the USA. They will also hear arguments for and against treatments such as nipple-sparing mastectomy in the patient with breast cancer and the timing of reconstruction vis-a-vis postmastectomy radiation therapy. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options available
for breast cancer coordinated care, but also to encourage the development of more standardized treatment strategies and protocols in the local treatment of breast cancer.

CONFERENCE OBJECTIVES Following this program, participants should have a thorough understanding of the important controversial aspects of coordinated local treatment of breast cancer and breast reconstruction. At the end of the activity, attendees will be able to:

✲ be aware of the pros and cons regarding prophylactic mastectomy, as well as the pros and cons regarding nipple-sparing in both prophylactic and therapeutic mastectomy.

✲ understand surgical techniques designed to improve the likelihood of nipple preservation and reduce the risk of flap or nipple necrosis with mastectomy.

✲ have a more complete understanding of the impact of reconstruction on post-mastectomy radiation delivery and, conversely, of the impact of post-mastectomy radiation on prior reconstruction.

✲ learn different philosophies regarding radiation delivery including new techniques and how to minimize side effects to the surrounding tissue.

✲ obtain a better understanding of the arguments regarding re-staging patients after neoadjuvant chemotherapy and the pros and cons of downstaging based upon response to chemotherapy pre-mastectomy on the subsequent treatment plan, the scope and power of oncoplastic surgery in the patient who undergoes breast conservation therapy for breast cancer, and the arguments in favor of a coordinated team approach in oncoplastic surgery to maximize the cosmetic and oncologic outcomes.

✲ become familiar with different methods of breast reconstruction including implant based reconstruction, flap-based reconstruction, and microsurgical-assisted free flap reconstruction.

✲ become aware of the proper patient selection and timing for these procedures as well as the evolving role of alloplastic materials in breast reconstruction both in terms of enhancing and facilitating device reconstruction of the breast, as well as reconstructing the abdomen after flap harvesting.

ACCREDITATION / CONTINUING EDUCATION POINTSThe Georgetown University Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Georgetown University Hospital designates this educational activity for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Georgetown University Hospital Department of Nursing Education is an approved provider of continuing nursing education by the Maryland Nurses Association, an accredited provider by the American Nurses Credentialing Center’s Commission on accreditation. Nurses will be awarded a maximum of 15 contact hours for successfully completing the program

Certificates of Attendance for CME and Contact Hours will be issued ONLINE, after BC3 2012 has occurred and hours of online attendance are verified. ONLINE attendance of this conference via PORTAL Education still allows claiming of CME/CPD points for attendees from the United States, Australia and for some Medical Personnel worldwide. This activity has been been approved by the Royal Australasian College of Surgeons (RACS) for approval within their CPD program. Fellows of RACS can claim one point per hour up to a maximum of 15 points in Category 4 . If you are outside of the United States and Australia then you should confirm CME/CPD requirements with your relevant Registration Bodies.

ALL INQUIRES REGARDING CME SHOULD BE DIRECTED AT THE CONFERENCE ORGANIZERS VIA: Quincy@bc3conference.com

PORTAL Education member tracking will identify logged hours and event(s) viewed. This can be verified by PORTAL Support at anytime. Please be aware that your attendance is tracked.

TARGET AUDIENCE This program is specifically designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information regarding the local treatment of breast cancer. The program is purposely targeted for general, plastic, breast and oncologic surgeons, as well as radiation & medical oncologists. It is also intended for primary care physicians, oncology nurses and practitioners, genetic counselors and hospital administrators who have an interest in the treatment of breast cancer patients